Tag: nasdaq:lgnd

April 7, 2021

5 Top Biotechnology ETFs

For investors looking for less volatility compared to stocks, here's an overview of the five largest biotechnology ETFs for consideration.
February 3, 2020

Ligand’s Technologies Support Potential Coronavirus Treatments

Ligand's proprietary technologies are being utilized by partners to enable potential treatments for the 2019 novel coronavirus, 2019-nCoV.
January 25, 2019

Ligand Partner Seelos Therapeutics Becomes a Public Company

Ligand Pharmaceuticals (NASDAQ:LGND) partner Seelos Therapeutics (NASDAQ:SEEL) announced that it has closed a reverse merger with Apricus Biosciences. As quoted in...
January 1, 2019

An Investor’s Guide to Clinical Trials

Clinical trials can be one of the more challenging US Food and Drug Administration processes to understand, but grasping the...
November 21, 2018

Ligand Partners with iMetabolic Biopharma

The agreement will allow iMetabolic to fully access Ligand’s OmniAb therapeutic antibody platform, which includes OmniRat, OmniMouse, OmniFlic and OmniChicken.
November 21, 2018

Ligand Announces OmniAb Partnership with iMetabolic Biopharma

Ligand Pharmaceuticals (NASDAQ:LGND) announces it has entered into a worldwide OmniAb partnership with iMetabolic Biopharma (iMBP), an early stage biopharma...